Navigation Links
Drug to Lower Cholesterol Underused

Despite the health benefits of drugs that lower cholesterol levels, research shows they remain underused.//

Lipid-lowering drugs can be started when a patient is in the hospital or at a follow-up appointment with a doctor. Researchers from Cleveland Clinic Foundation looked at the relationship between when lipid-lowering therapy is started during a hospital stay vs. in an outpatient setting and its long-term use.

For the study, researchers used information from patients from 69 centers in the United States and Canada. The patients were all part of a previous study. Researchers found 175 patients were all discharged taking cholesterol-lowering therapy and 1,951 were discharged without the therapy. Researchers then looked at who was put on the therapy and how long they adhered to the drug regimen.

After six months, 77 percent of the patients who started taking the drugs before they left the hospital continued taking the medicine compared to 25 percent of those who started the therapy after leaving the hospital. Researchers say they found that initiation of lipid lowering agents before discharge was the most important independent predictor of their use at follow-up and patients in whom lipid-lowering therapy was initiated before discharge were nearly three times as likely to be taking these agents six months later.

Researchers say more studies looking at other factors that can influence the long-term use of these drugs need to be done.


'"/>




Page: 1

Related medicine news :

1. Simvastatin Plus Niacin May Lower Heart Risks
2. Ritalin May Lower Cocaine Abuse
3. Eating More Often May Help Lower Cholesterol
4. Lower surgical volume linked to higher death rate
5. Lowering blood pressure beneficial for PAD patients
6. Lower chance of bone fracture with Vitamin D supplementation
7. Tea Pill Lowers Cholesterol
8. Aspirin Lowers Leukemia Risk
9. Almonds Help Lower Cholesterol
10. Lowering Risk of Breast Cancer Recurrence
11. Multi-Drug Therapy Effective in Lowering Blood Pressure

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Drug Lower Cholesterol Underused

(Date:11/8/2009)... legislation would strengthen Medicare, improve co...PRNewswire-USNewswire/ -- SUMMARY: Yesterday the...tical health care reform legislation that would st...on by insurance companies that prices millions of ..., The Affordable Health Care for America Act (H.R...
(Date:11/8/2009)... UCW Academy of Health holds open house ...oria, BC (Vocus) November 8, 2009 -- UCW Academy o...in British Columbia’s health care industry t..., November 25, 2009. , ,UCW Academy of Health, wh...n, nursing and social services, designs its progra...
(Date:11/8/2009)...N, Nov. 7 Tonight the H...th Care for America Act, landmark health reform le...ss to quality, affordable, stable and secure healt...n on some of the insurance industry,s worst practi... and cut the deficit by $104 billion over ten year...
(Date:11/8/2009)... Men’s Health Network (MHN) urges ...s, especially those linked to exposure to chemical...ervice. Bladder cancer is one of those cancers tha...lly those who once smoked or currently smoke cigar...RWEB) November 8, 2009 -- Men’s Health Netwo...
(Date:11/8/2009)... largest network of Hispanic health advocates comm...n 2009 ,, WASHINGTON, Nov. 7 /PRNewswire-USNew...es showed they have heard the voice of America,s f...America Act. Now the Senate must deliver, without ...form," said Dr. Jane L. Delgado, President and CEO...
Breaking Medicine News(10 mins):Health News:AARP NY Praises House Passage of Health Care Reform Bill 2Health News:AARP NY Praises House Passage of Health Care Reform Bill 3Health News:AARP NY Praises House Passage of Health Care Reform Bill 4Health News:College Invites Public to Explore Career Options in Health Care 2Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 2Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 3Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 2Health News:Veterans' Day Reminder from Men's Health Network: Pay Attention to Bladder Cancer Symptoms and Risk Factors 3Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2
...ratures mean more ozone, and more strain on hearts...HealthDay News) -- Soaring temperatures and high o...m heart disease and stroke, researchers report. , ...s. , "Temperature and ozone are strong factors in ...
...,S PICK: Pregnant women pass on the effects of smo...rse effects on fetal development. A new study in m...versity of Toronto, Canada, now adds the possibili...egative outcomes. , , The authors found that fema...
...HIA Researchers from the Abramson Cancer Center o...hat findings from two large, international clinica...with multiple myeloma, a cancer that occurs in the...patients significantly improved by all measures wh...
...ANCISCO, Calif., Nov. 21 Rigel,Pharmaceuticals, I...host a,conference call with simultaneous webcast t...y of R788, a novel, oral Syk kinase inhibitor, in,...ment and the principal investigator on the study, ...
...C., Nov. 21 The National Business Coalition,on He...South Carolina an,eValue8 Health Plan Innovation A...he award recognizes programs that address critical...nt and,continuity of care for members with severe ...
...v. 21 Flagship Global Health,Inc. ("Flagship") (O...f,John Flood as its new Chief Executive Officer. C... of Flagship. Mr. Flood has been President of,Flag...s on the strategic direction of the Company., "Ha...
Other Medicine News:Health News:Global Warming May Trigger Rise in Heart Deaths 2Health News:Global Warming May Trigger Rise in Heart Deaths 3Health News:JCI table of contents: Nov. 21, 2007 2Health News:JCI table of contents: Nov. 21, 2007 3Health News:JCI table of contents: Nov. 21, 2007 4Health News:JCI table of contents: Nov. 21, 2007 5Health News:JCI table of contents: Nov. 21, 2007 6Health News:JCI table of contents: Nov. 21, 2007 7Health News:JCI table of contents: Nov. 21, 2007 8Health News:JCI table of contents: Nov. 21, 2007 9Health News:JCI table of contents: Nov. 21, 2007 10Health News:Penn's Abramson Cancer Center part of major phase III study for myeloma 2Health News:Penn's Abramson Cancer Center part of major phase III study for myeloma 3Health News:Rigel to Host Conference Call to Discuss Phase 2 Study Results of R788 in ITP 2Health News:Rigel to Host Conference Call to Discuss Phase 2 Study Results of R788 in ITP 3Health News:Business Coalition Honors BlueChoice HealthPlan for Migraine Program 2Health News:John H. Flood III Named as CEO of Flagship Global Health, Inc. 2
(Date:11/6/2009)...wswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. ...previously approved reverse split of its common st...nday, Nov. 9, 2009 on a 1-for-15 split-adjusted ba...e under the new symbol OXBT. The stock also will h...t becomes effective. ,, "This reverse split was...
(Date:11/6/2009)... Pa., Nov. 6 In consultation with ...l Consumer Healthcare, Division of McNEIL-PPC, Inc...umber of product lots of TYLENOL® Arthritis P... red EZ-OPEN CAP. McNeil is initiating the recall ...te associated with these lots that led to a small ...
(Date:11/6/2009)...ire/ -- Trius Therapeutics, Inc. announced today t...S-1 with the U.S. Securities and Exchange Commissi...ering of shares of its common stock. All shares of...be offered by the Company. ,, Credit Suisse Sec...anager, Piper Jaffray & Co. is acting as co-le...
Breaking Medicine Technology:Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 2Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 3McNeil Consumer Healthcare Announces Voluntary Recall of Certain Lots of TYLENOL(R) Arthritis Pain 100 Count with EZ-OPEN CAP 2Startech Environmental Advises Shareholders to Take No Action in Response to Friendly LRL Tender Offer 50901 1Startech Environmental Advises Shareholders to Take No Action in Response to Friendly LRL Tender Offer 50901 2Startech Environmental Advises Shareholders to Take No Action in Response to Friendly LRL Tender Offer 50901 3HMS Awarded Third Party Data Match and Recovery Contract by Mississippi Medicaid 50897 1Fortune Recognizes Female Health Company as One of Americas Fastest Growing Small Companies 50895 1Fortune Recognizes Female Health Company as One of Americas Fastest Growing Small Companies 50895 2Fortune Recognizes Female Health Company as One of Americas Fastest Growing Small Companies 50895 3Fortune Recognizes Female Health Company as One of Americas Fastest Growing Small Companies 50895 4
...IANAPOLIS, Sept. 20 Eli Lilly and Company,(NYSE: ...plication with the,European Medicines Agency (EMEA...for injection), in combination with cisplatin, for...ll lung cancer (NSCLC). ALIMTA is currently indic...ingle agent for the treatment of patients with loc...
...When compared to insulin glargine, exenatide offer...ta-cell function when used with metformin --, AMS...als, Inc. (Nasdaq: AMLN ) and Eli Lilly and Compa...paring treatment of exenatide injection,with insul...l and weight in,people with type 2 diabetes. Study...
Other Medicine Technology:Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer 2Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer 3Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer 4Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer 5Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer 6Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer 7Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer 8Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer 9Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer 10Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer 11Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer 12One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 2One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 3One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 4One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 5One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 6One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 7
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
Medicine Products: